LUPINlow · TIE-UP
Lupin Limited — VISUfarma B.V., the Netherlands, a wholly owned subsidiary of the Company, has entered into an Exclusive License Agreement with Visus Therapeutics, Inc. U.S.A.
Lupin · Healthcare · filed 20 Aug, 18:05 IST
Why we say this
The facts in the filing itself.
- Lupin Limited has informed the Exchange about VISUfarma B.V., the Netherlands, a wholly owned subsidiary of the Company, has entered into an Exclusive License Agreement with Visus Therapeutics, Inc. U.S.A.
- Filed with NSE on 2026-08-20 under the category "Arrangements for strategic, technical, manufacturing, or marketing tie up". Classified from that category alone — no model and no PDF, because NSE has no category for losing an order or reducing capacity.
What this kind of filing means
About tie-up filings in general.
An agreement to work with another company — manufacturing, distribution, technology. A signed intention, not yet a result.
ExampleMany memoranda of understanding never turn into revenue.
About this kind of filing — not a reading of this one.